Article

Retina Roundtable Session 3

Subscribe

In this third session, the physicians discuss how they communicate to their patients the increased risk of stroke that may be associated with dosing of anti-VEGF agents.

Participants include:

Return to Retina Roundtable Podcast Series

Return to Ophthalmology Times Radio

Related Videos
Image credit: Ophthalmology Times; Angiogenesis 2025: Encapsulated cell therapy for MacTel shows long-term efficacy in phase 3 trials
Image credit: Ophthalmology Times; Dean McGee Eye Institute resident Ashley Ooms, MD, explores gray area strabismus surgery complications in AUPO poster
© 2025 MJH Life Sciences

All rights reserved.